BioLineRx Ltd (BLRX)

2.95
+0.05(+1.72%)
After Hours
2.94
-0.01(-0.339%)
- Real-time Data
  • Volume:
    1,570,858
  • Bid/Ask
    2.80/2.95
  • Day's Range
    2.76 - 3.10

BLRX Overview

Prev. Close
2.95
Day's Range
2.76 - 3.1
Revenue
0
Open
3.02
52 wk Range
1.1 - 4.23
EPS
0
Volume
1,570,858
Market Cap
127.76M
Dividend (Yield)
N/A (N/A)
Average Volume (3m)
2,726,270
P/E Ratio
N/A
Beta
0
1-Year Change
55.67%
Shares Outstanding
0
Next Earnings Date
25 May 2021
What is your sentiment on BioLineRx Ltd?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellSellSell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellBuy
SummaryStrong BuyBuyStrong SellStrong SellNeutral

BioLineRx Ltd Company Profile

BioLineRx Ltd Company Profile

Employees
48
Market
Israel

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.